C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01) A61K 31/415 (2006.01) A61K 31/495 (2006.01) A61K 31/55 (2006.01) C07D 235/26 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01)
Patent
CA 2114542
Image Pharmacologically active benzimidazolone derivatives as 5-HT1A and 5-HT2 receptors, useful in the treatment of CNS disorders of formula (I), wherein R1 and R2 may be at the same time or not a hydrogen atom, halogen, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxy- carbonyl, hydroxy, nitro, amino optionally C1-4 alkyl N-mono or di-substituted, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally C1-4 alkyl N-mono or di-substituted, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, amino sulphonyl optionally C1-4 alkyl N-mono or di-substituted, Ct.~ al- kyl N-mono or di-substituted aminosulphonylamino, aminosulphonylamino; R3 is hydrogen, C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl; A is -CO- or -CONH- or it is absent; B is a straight or branched, saturated or unsaturated C2-6 alkyl; m and n are both independently an integer from 1 to 3; R4 is an aryl, aralkyl, a heteroaryl, or heteroaralkyl group, each group being optionally substituted by one or more substituents selected from halogen, trifluoromethyl, cyano, C1-3 alkoxy, C1-4 alkyl and acid addition salts thereof. The process for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.
Bietti Giuseppe
Bignotti Maura
Borsini Franco
Giraldo Ettore
Turconi Marco
Boehringer Ingelheim Italia S.p.a.
Fetherstonhaugh & Co.
LandOfFree
Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1418954